logo banner home news contact
nav
technology
therapeutic platforms
product pipeline
publications

 

Product Pipeline

Description Indication Status
AGS-0031 Metastatic Renal Cell Carcinoma Ph 2
AGS-0041 HIV Ph 2
CD83 Soluble Protein Transplant Rejection/Autoimmune Disorders Preclinical
Anti IFN-alpha Monoclonal Antibody2 Lupus Preclinical
Regulatory T Cell Therapy3 Autoimmune Disorders Preclinical

1 – Co-developing with Kirin Brewery’s Pharmaceutical Division.
2 – Licensed to Novo Nordisk.
3 – Licensed to Therakos(J&J)